Long-acting β(2)-agonists in asthma: safety concerns

Ítems similars

• Review: Safety of long-acting β2 -agonists in the treatment of asthma
  per: Mario Cazzola, et al.
  Publicat: (2007-10-01)
• Assessment of the safety of long-acting β(2)-agonists in routine asthma care: the ASTRO-LAB protocol
  per: Van Ganse, Eric, et al.
  Publicat: (2015)
• Safety of long-acting β(2)-agonists in the management of asthma: A Primary Care Respiratory Alliance of Canada perspective
  per: D’Urzo, Anthony D., et al.
  Publicat: (2010)
• Efficacy and safety of the CRTh2 antagonist AZD1981 as add-on therapy to inhaled corticosteroids and long-acting β(2)-agonists in patients with atopic asthma
  per: Bateman, Eric D, et al.
  Publicat: (2018)
• Combining inhaled glucocorticoids and long acting β(2)-adrenoceptor agonists in asthma and COPD
  per: Knox, A J, et al.
  Publicat: (2008)